evernic acid has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crawford, AD; Esguerra, CV; Franzblau, SG; Lauinger, IL; Maes, L; Perozzo, R; Pham, DH; Stairiker, C; Tarun, A; Tasdemir, D; Tonge, PJ; Vivas, L; Xu, H; Zhang, X; Zloh, M | 1 |
| Chang, SC; Hong, DG; Hur, JS; Ishigami, A; Kim, H; Lee, J; Lee, S; Suh, YJ; Yang, S | 1 |
2 other study(ies) available for evernic acid and Disease Models, Animal
| Article | Year |
|---|---|
Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target.
Topics: Animals; Antimalarials; Disease Models, Animal; Enzyme Inhibitors; Fatty Acid Synthase, Type II; Hepatocytes; Humans; Lichens; Liver; Malaria; Molecular Structure; Mycobacterium tuberculosis; Plasmodium berghei; Plasmodium falciparum; Protozoan Proteins; Staphylococcus aureus; Zebrafish | 2013 |
Neuroprotective and Anti-Inflammatory Effects of Evernic Acid in an MPTP-Induced Parkinson's Disease Model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Apoptosis; Astrocytes; Cells, Cultured; Disease Models, Animal; Dopaminergic Neurons; Drug Evaluation, Preclinical; Hydroxybenzoates; Lichens; Male; Mice, Inbred C57BL; Mitochondria; Motor Activity; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Parkinson Disease; Signal Transduction | 2021 |